Depression and Anxiety Trial, Recruiting NCT06489639 Sponsor: Klaus Ranta Condition: Depression and Anxiety
Back to Depression And Anxiety

Depression and Anxiety Trial, Recruiting

NCT06489639
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are between 13 and 17 years old
  • People who have been diagnosed with Social Anxiety Disorder (a condition where someone feels very strong fear or anxiety in social situations) according to standard diagnostic guidelines
  • People for whom Social Anxiety Disorder is their main mental health concern, rather than another condition
  • Both the young person and their parent or guardian are willing and motivated to take part in the treatment program as the study requires
  • People who have a good understanding of the Finnish language

Who may not be able to join:

  • People who have an intellectual disability
  • People whose primary diagnosis is autism spectrum disorder
  • People who are experiencing significant symptoms of psychosis or have a psychotic disorder
  • People who have a severe eating disorder, severe depression, or another anxiety disorder that needs to be treated urgently before social anxiety can be addressed
  • People who are currently at risk of suicide or are having thoughts of ending their life
  • People whose use of alcohol or other substances requires involvement from child protection services
  • People whose home or surrounding environment involves serious risk factors that require child protection measures

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 14 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Klaus Ranta, MD, PhD, Tampere University

Phone: +358 504418286

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Klaus Ranta
Registry
ClinicalTrials.gov
Start date
20 March 2023
Est. completion
31 December 2027

Where this trial is recruiting

🇫🇮 Finland

Primary endpoints

Self-reported social anxiety symptoms; Diagnostic status of SAD; Clinical severity of SAD symptoms

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov